Month: <span>November 2022</span>

Home / 2022 / November
Post

Adding sensory integration to autism assessments may yield more individualized treatment

THOMAS JEFFERSON UNIVERSITY PHILADELPHIA – People with autism are often portrayed in popular media as experiencing difficulty processing highly stimulating or overly loud environments. While this is certainly true for many, there can be a wide diversity in the ways people comprehend the information they perceive from all senses. New research from Thomas Jefferson University,...

Monkeypox mutations cause virus to spread rapidly, evade drugs and vaccines, MU study finds
Post

Monkeypox mutations cause virus to spread rapidly, evade drugs and vaccines, MU study finds

UNIVERSITY OF MISSOURI-COLUMBIA IMAGE: VIRUS CREDIT: UNIVERSITY OF MISSOURI COLUMBIA, Mo. – Monkeypox has infected more than 77,000 people in more than 100 countries worldwide, and — similar to COVID-19 — mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and vaccines in its mission to infect more people. Now, a...

Triglyceride-lowering trial neutral for cardiovascular event reduction
Post

Triglyceride-lowering trial neutral for cardiovascular event reduction

by Brigham and Women’s Hospital Credit: Pixabay/CC0 Public Domain Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice. Yet, in a major randomized trial of the novel drug pemafibrate, researchers found no reduction in rates of heart attack, stroke,...

Monkeypox mostly spreads before symptoms appear, study suggests
Post

Monkeypox mostly spreads before symptoms appear, study suggests

Credit: Pixabay/CC0 Public Domain People with monkeypox can spread the virus up to four days before symptoms appear, with more than half of transmissions potentially taking place during this period, a UK study estimated Tuesday. While the findings have yet to be confirmed, they suggest that many monkeypox infections cannot be prevented by asking patients...

Conservative management vs. dialysis for preventing hospitalizations in patients with advanced kidney diseases
Post

Conservative management vs. dialysis for preventing hospitalizations in patients with advanced kidney diseases

by American Society of Nephrology Credit: Unsplash/CC0 Public Domain For some individuals with advanced kidney disease, dialysis may not be the optimal treatment strategy for their condition, and these patients may be better served with conservative non-dialytic management that focuses on quality of life and symptom control. Investigators recently examined the differential impact of conservative...

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease
Post

Researchers identify a subset of patients with early melanoma who face a very low risk of dying from the disease

by Wiley Credit: Wikimedia Commons/National Cancer Institute Although melanoma is the most serious type of skin cancer, most patients have high chances of surviving the disease. There is evidence that more cases of melanoma are being overdiagnosed in patients who would never experience symptoms. Using cancer registry data, investigators have identified a subset of patients...

Researchers find most commonly prescribed class of anti-depressant medications do not reduce COVID severity
Post

Researchers find most commonly prescribed class of anti-depressant medications do not reduce COVID severity

by Intermountain Healthcare  An Intermountain Healthcare ICU nurse cares for a patient with COVID. A new study by researchers at Intermountain Healthcare in Salt Lake City finds that the most commonly prescribed class of anti-depressants does not help reduce the severity of illness or even death for people who get COVID, as once thought. Credit:...

Clinical trial finds novel therapy markedly reduces lipoprotein(a) levels in people with cardiovascular disease
Post

Clinical trial finds novel therapy markedly reduces lipoprotein(a) levels in people with cardiovascular disease

by Brigham and Women’s Hospital Credit: Pixabay/CC0 Public Domain Lipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological therapies to decrease its concentration in the bloodstream. Olpasiran is an investigational drug that reduces lipoprotein(a) concentration by degrading the RNA that codes for...

Follow-up care with medication, testing after heart attack can prevent 94% of patients from having second cardiac event
Post

Follow-up care with medication, testing after heart attack can prevent 94% of patients from having second cardiac event

by Intermountain Healthcare  Credit: Intermountain Healthcare A new study by researchers at Intermountain Healthcare in Salt Lake City finds that following up a cardiac event, such as a heart attack, with a statin prescription and cholesterol measuring blood test, prevents 94% of patients from having or dying from a second cardiovascular event during the next...